Skip to main content

Table 2 Determination of IC 50 values for mavacoxib and carprofen in KTOSA5 and CSKOS cells sorted for CD34 protein expression

From: The long-acting COX-2 inhibitor mavacoxib (Trocoxil™) has anti-proliferative and pro-apoptotic effects on canine cancer cell lines and cancer stem cells in vitro

  

IC50

Cell type

Drug

CD34-

CD34+

KTOSA5

Mavacoxib

38.63 μM

27.37 μM

KTOSA5

Carprofen

42.94 μM

44.87 μM

CSKOS

Mavacoxib

37.62 μM

36.03 μM

CSKOS

Carprofen

55.86 μM

49.6 μM

  1. All measurements were made in triplicate.
Back to article page

BMC Veterinary Research

ISSN: 1746-6148

Contact us